All sites C00-96,D32-33,D42-43,D45-47,D76 2628 89.9 1.6 3.6 1.2 3.6
Mouth, pharynx C00-14 43 98.1 0.9 0.9 - -
  Lip C00 7 97.1 - 2.9 - -
  Tongue C02 11 100.0 - - - -
  Mouth, other C03-06 12 100.0 - - - -
  Salivary glands C07-08 5 91.3 8.7 - - -
  Pharynx C01,C09-14 8 97.6 - 2.4 - -
Digestive organs C15-26 505 80.3 0.8 10.2 2.6 6.2
  Oesophagus C15 16 95.0 - 2.5 1.3 1.3
  Stomach C16 54 95.2 - 1.5 0.4 3.0
  Small intestine C17 8 95.0 - 5.0 - -
  Colon C18 176 93.4 0.1 2.5 1.0 2.9
  Rectum, rectosigmoid C19-20 75 98.1 - 0.8 0.5 0.5
  Anus C21 4 100.0 - - - -
  Liver C22 30 69.8 4.0 15.4 6.0 4.7
  Gallbladder, bile ducts C23-24 25 52.0 4.1 24.4 4.9 14.6
  Pancreas C25 106 48.4 1.3 30.3 5.5 14.5
  Other digestive organs C26 11 33.3 - 18.5 16.7 31.5
Respiratory organs C30-39 153 73.9 9.0 8.5 2.5 6.1
  Nose, sinuses C30-31 2 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 145 74.1 9.4 8.5 2.3 5.6
  Mediastinum, pleura C38 1 33.3 - 50.0 - 16.7
Bone C40-41 2 91.7 - - - 8.3
Melanoma of the skin C43 106 100.0 - - - -
Skin, non-melanoma C44 133 99.7 - - 0.2 0.2
Mesothelioma C45 4 100.0 - - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 17 97.7 - 1.2 - 1.2
Breast C50 819 99.4 0.2 0.0 0.1 0.3
Female genital organs C51-58 298 93.4 0.9 2.3 1.5 1.8
  Cervix uteri C53 26 99.2 0.8 - - -
  Corpus uteri C54 144 98.3 0.1 0.4 0.4 0.7
  Uterus, other C55,C58 2 41.7 - 25.0 25.0 8.3
  Ovary C56 92 87.6 1.7 5.9 1.7 3.1
  Other female genital C51-52,C57 33 87.3 2.4 1.2 4.8 4.2
Urinary organs C64-68 116 88.0 1.0 5.7 1.5 3.8
  Kidney C64 69 85.3 - 8.4 1.7 4.6
  Bladder and urinary tract2 C65-68 47 91.9 2.6 1.7 1.3 2.6
Eye C69 2 77.8 - 11.1 - 11.1
Brain, central nervous system C70-72,D32-33,D42-43 104 88.8 - 4.2 1.0 6.0
Thyroid gland C73 44 96.8 2.7 0.5 - -
Other endocrine glands C74-75 1 83.3 - - 16.7 -
Illdefined or unknown C76,C80 68 55.3 7.6 15.0 4.4 17.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 211 80.9 6.2 0.9 1.1 10.9
  Hodgkin lymphoma C81 12 98.3 - - - 1.7
  Non-Hodgkin lymphoma C82-86,C96,D76 93 97.8 0.6 - 0.2 1.3
  Malignant immunoproliferative diseases C88 2 80.0 - - - 20.0
  Myeloma and other plasma cell tumors C90 27 66.2 9.6 6.6 2.9 14.7
  Leukaemia C91-95 47 68.4 14.8 - 2.1 14.8
  Myelodysplastic syndromes D46 12 29.3 22.4 - - 48.3
  Myeloproliferaitive neoplasms D45,D47 18 70.7 2.2 - 2.2 25.0
Not included above
  Carcinoma in situ of the breast D05 71 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 180 100.0 - - - -
  Borderline tumour of the ovary D39 27 98.5 - - - 1.5
  Basal cell carcinoma of the skin 738 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.